Ex-FDA com­mish Scott Got­tlieb makes a quick jump back on­to the mon­ey side of biotech

Well, that didn’t take long.

Just a lit­tle more than a month af­ter Scott Got­tlieb’s sur­prise ex­it at the FDA, the for­mer com­mish is back on the mon­ey side of the in­dus­try he had been in charge of reg­u­lat­ing for 2 years. He’s re­join­ing New En­ter­prise As­so­ciates as a full-time in­vest­ing part­ner, where he ex­pects to start back­ing biotech star­tups and sit­ting on boards again.

Ax­ios got the scoop on Wednes­day, which Got­tlieb — who’s been well known for keep­ing his ed­i­to­r­i­al con­tacts close — quick­ly con­firmed in a Tweet.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER